Medication nonadherence is a global challenge with profound implications for patient health outcomes and healthcare systems. Studies have shown that up to 50% of patients discontinue antihypertensive ...
Former Pfizer CEO Ian Read Joins Hoot as Strategic Advisor to Address Pharma's Failed Patient Starts, Poor Adherence, and Clinical Trial Dropouts PRINCETON, N.J., Feb. 25, 2026 /PRNewswire/ -- Hoot ...
MedPage Today on MSNOpinion
We've All Had 'Difficult' Patients. But Do They Really Exist?
Instead of labeling them, let's find out what's really causing the problem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results